Amphastar Pharma Contracts & Agreements
74 Contracts & Agreements
- Business Finance (42 contracts)
- Business Operations (11)
- Human Resources (12)
- Uncategorized (9)
- Distribution Agreement by and between Armstrong Pharmaceuticals, Inc. and Hong Kong Genreach Limited, dated August 28, 2024 (Filed With SEC on November 7, 2024)
- 2015 Equity Incentive Plan of Amphastar Pharmaceuticals, Inc. (as amended and restated) (Filed With SEC on June 4, 2024)
- Indenture, dated September 15, 2023, between Amphastar Pharmaceuticals, Inc. and U.S. Bank Trust Company, National Association, as trustee (Filed With SEC on September 15, 2023)
- Purchase Agreement, dated September 12, 2023, among Amphastar Pharmaceuticals, Inc. and Jefferies LLC, J.P. Morgan Securities LLC, Wells Fargo Securities, LLC and BofA Securities,... (Filed With SEC on September 15, 2023)
- Asset Purchase Agreement by and among Amphastar Pharmaceuticals, Inc., Amphastar Medication Co., LLC, and Eli Lilly and Company, dated April 21, 2023 (Filed With SEC on August 9, 2023)
- Manufacturing Service Agreement by and between Amphastar Pharmaceuticals, Inc., and Eli Lilly and Company, dated June 30, 2023 (Filed With SEC on August 9, 2023)
- Transition Service Agreement by and between Amphastar Pharmaceuticals, Inc., and Eli Lilly and Company, dated June 30, 2023 (Filed With SEC on August 9, 2023)
- Amendment to Contact Research Agreement by and between Amphastar Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd., dated March 8, 2023 (Filed With SEC on May 9, 2023)
- Supply Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc. and Nanjing Letop Biotechnology Co., Ltd. dated November 15, 2022 (Filed With SEC on November 18, 2022)
- Contract Research Agreement by and between Amphastar Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd, dated July 5, 2022 (Filed With SEC on November 8, 2022)
- Contract Manufacturing Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc. and Nanjing Hanxin Pharmaceutical Technology Co., Ltd, dated April 19, 2022 (Filed With SEC on August 9, 2022)
- Sixth Amendment to the Supply Agreement by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc., dated May 24, 2021 (Filed With SEC on August 9, 2021)
- Share Purchase Agreement by and between Amphastar Pharmaceuticals, Inc., Nanjing Zhongpan Enterprise Management Consulting Center (LLP), Nanjing Zhanrun Enterprise Management... (Filed With SEC on August 9, 2021)
- Share Repurchase Agreement by and between Amphastar Nanjing Pharmaceuticals, Inc., Nanjing Qianqia Enterprise Management Consulting (LLP), Nanjing Zhongpan Enterprise Management... (Filed With SEC on August 9, 2021)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 15, 2021)
- Eight Modification to the Revolving Line of Credit Agreement, dated March 7, 2016, between International Medication Systems, Limited and East West Bank in the principal sum of... (Filed With SEC on March 15, 2021)
- Equipment Line of Credit, dated September 1, 2020, between International Medication Systems, Limited and East West Bank in the original sum of $10,000,000 (Filed With SEC on November 6, 2020)
- Eighth Modification to the Revolving Line of Credit Agreement, dated June 15, 2020, between Amphastar Pharmaceuticals, Inc. and Armstrong Pharmaceuticals, Inc. and Cathay Bank in... (Filed With SEC on August 10, 2020)
- Separation Agreement and General Release of Claims by and between the Company and Jason Shandell dated as of April 13, 2020 (Filed With SEC on August 10, 2020)
- Amphastar Pharmaceuticals, Inc. Employee Deferred Compensation Plan, effective December 1, 2019 (Filed With SEC on March 16, 2020)
- Description of Securities Registered Under Section 12 of the Exchange Act (Filed With SEC on March 16, 2020)
- Ninth Amendment to the Acquisition Loan, dated July 19, 2019 between Amphastar Pharmaceuticals, Inc. and Cathay Bank (Filed With SEC on August 9, 2019)
- Fifth Amendment to the Supply Agreement by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc., dated August 2, 2019 (Filed With SEC on August 9, 2019)
- First Modification to the Loan Agreement, dated April 22, 2019, between Amphastar Pharmaceuticals, Inc. and Cathay Bank (Filed With SEC on May 10, 2019)
- Equipment Line of Credit, dated January 8, 2019, between International Medication Systems, Limited and East West Bank in the original principal sum of $10,000,000 (Filed With SEC on May 10, 2019)
- Fourth Amendment to Supply Agreement, dated December 24, 2018, by and between MannKind Corporation and Amphastar Pharmaceuticals, Inc (Filed With SEC on March 15, 2019)
- Subscription Agreement between Amphastar Cayman, LLC and KYW Investment partnership dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Jason B. Shandell dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and William J. Peters dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Rong Zhou dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Yakob Liawatidewi dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Stephen B. Shohet dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Chieh-Lin J. Lee dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Subscription Agreement between Amphastar Cayman, LLC and Yu-Chieh W. Lee dated June 28, 2018 (Filed With SEC on August 9, 2018)
- Partnership Agreement by and between Zhang Chongqing, Bill Zhang and Applied Physics & Chemistry Laboratories, Inc. dated July 27, 2018 (Filed With SEC on August 9, 2018)
- Business Loan Agreement, dated August 14, 2017, between Armstrong Pharmaceuticals, Inc. and Cathay Bank in the original principal sum of $7,865,000 (Filed With SEC on November 9, 2017)
- Equipment Line of Credit, dated June 28, 2017, between International Medication Systems, Limited and East West Bank in the original principal sum of $8,000,000 (Filed With SEC on August 9, 2017)
- Business Loan Agreement, dated May 11, 2017, between International Medication Systems, Limited and East West Bank in the original principal sum of $5,000,000 (Filed With SEC on August 9, 2017)
- Business Loan Agreement, dated May 18, 2017, between Amphastar Pharmaceuticals, Inc. and East West Bank in the original principal sum of $9,000,000 (Filed With SEC on August 9, 2017)
- Sixth Modification to the Revolving Line of Credit Agreement, dated May 3, 2017, between International Medication Systems, Limited and East West Bank in the principal sum of... (Filed With SEC on August 9, 2017)
- CONFIDENTIAL TREATMENT REQUESTED CONFIDENTIAL PORTIONS OF THIS DOCUMENT HAVE BEEN REDACTED AND HAVE BEEN SEPARATELY FILED WITH THE SECURITIES AND EXCHANGE COMMISSION SECOND... (Filed With SEC on March 15, 2017)
- BUSINESS LOAN AGREEMENT (Filed With SEC on November 9, 2016)
- FOURTH MODIFICATION AGREEMENT (Filed With SEC on August 9, 2016)
- CORPORATE RESOLUTION TO GRANT COLLATERAL / GUARANTEE (Filed With SEC on May 10, 2016)
- CORPORATE RESOLUTION TO BORROW / GRANT COLLATERAL (Filed With SEC on May 10, 2016)
- BUSINESS LOAN AGREEMENT (Filed With SEC on March 15, 2016)
- AMPHASTAR PHARMACEUTICALS, INC. 2015 EQUITY INCENTIVE PLAN (Filed With SEC on June 1, 2015)
- FIRST AMENDMENT TO SUPPLY AGREEMENT (Filed With SEC on November 13, 2014)
- Supply Agreement (Filed With SEC on November 13, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. (a Delaware corporation) [] Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on June 18, 2014)
- Employment Agreement (Filed With SEC on May 20, 2014)
- Employment Agreement (Filed With SEC on May 20, 2014)
- Employment Agreement (Filed With SEC on May 20, 2014)
- Employment Agreement (Filed With SEC on May 20, 2014)
- REGISTRATION RIGHTS AGREEMENT Dated as of February 4, 2005 between AMPHASTAR PHARMACEUTICALS, INC. and LOTUS CHINA FUND, L.P. (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. AMENDED 2002 STOCK OPTION/STOCK ISSUANCE PLAN Approved by Stockholders on July 15, 2004 (Filed With SEC on May 20, 2014)
- Amphastar Pharmaceuticals, Inc. 2002 Stock Option/Stock Issuance Plan Notice of Stock Option Grant (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. AMENDED AND RESTATED 2005 EQUITY INCENTIVE AWARD PLAN ARTICLE 1 PURPOSE (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. AMENDED AND RESTATED 2005 EQUITY INCENTIVE AWARD PLAN Stock Option Grant Notice and Stock Option Agreement (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. Deferred Stock Unit Notice of Grant (Filed With SEC on May 20, 2014)
- DISTRIBUTION AGREEMENT (Filed With SEC on May 20, 2014)
- BUSINESS LOAN AGREEMENT (Filed With SEC on May 20, 2014)
- BUSINESS LOAN AGREEMENT (Filed With SEC on May 20, 2014)
- Employment Agreement (Filed With SEC on May 20, 2014)
- STANDARD OFFER, AGREEMENT AND ESCROW INSTRUCTIONS FOR PURCHASE OF REAL ESTATE (Non-Residential) AIR Commercial Real Estate Association (Filed With SEC on May 20, 2014)
- Transfer Contract for the Right to the Use of State-owned Land NKTZHZ [2009] No. (012) (Filed With SEC on May 20, 2014)
- Agreement Concerning Investment of Amphastar Nanjing Pharmaceuticals Co., Ltd. in Innovative Electronic Medical Equipment Project Date: July 5, 2010 Location: Nanjing (Filed With SEC on May 20, 2014)
- Transfer Contract for the Right to the Use of State-owned Land NKTZHZ [2010] No. (016) (Filed With SEC on May 20, 2014)
- LONG-TERM SUPPLY AGREEMENT (Filed With SEC on May 20, 2014)
- AMPHASTAR PHARMACEUTICALS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN (Filed With SEC on May 20, 2014)
- ASSET PURCHASE AGREEMENT (LONG FORM) AMONG DIOSYNTH FRANCE (AS SELLER) AMPHASTAR FRANCE PHARMACEUTICALS SAS (AS BUYER) AND SCHERING-PLOUGH April 30, 2014 (Filed With SEC on May 20, 2014)
- LOAN AGREEMENT (Filed With SEC on May 20, 2014)
- PROMISSORY NOTE (Filed With SEC on May 20, 2014)
